PRODUODOPA Israel - English - Ministry of Health

produodopa

abbvie biopharmaceuticals ltd, israel - foscarbidopa; foslevodopa - solution for infusion - foslevodopa 240 mg / 1 ml; foscarbidopa 12 mg / 1 ml - treatment of advanced levodopa-responsive parkinson’s disease with severe motor fluctuations and hyperkinesia or dyskinesia when available combinations of parkinson medicinal products have not given satisfactory results.

Produodopa 240 mg/ml + 12 mg/ml solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

produodopa 240 mg/ml + 12 mg/ml solution for infusion

abbvie limited - foslevodopa; foscarbidopa - solution for infusion - dopa and dopa derivatives

VYALEV foslevodopa 2400 mg/10 mL and  foscarbidopa 120 mg/10 mL solution for subcutaneous infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

vyalev foslevodopa 2400 mg/10 ml and foscarbidopa 120 mg/10 ml solution for subcutaneous infusion vial

abbvie pty ltd - foslevodopa, quantity: 2400 mg; foscarbidopa, quantity: 120 mg - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide - for the treatment of advanced idiopathic parkinson?s disease with severe motor fluctuations despite optimised alternative pharmacological treatment.

VYALEV SOLUTION Canada - English - Health Canada

vyalev solution

abbvie corporation - foslevodopa; foscarbidopa - solution - 240mg; 12mg - foslevodopa 240mg; foscarbidopa 12mg

VYALEV combination subcutaneous infusion (ヴィアレブ配合持続皮下注) Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

vyalev combination subcutaneous infusion (ヴィアレブ配合持続皮下注)

abbvie gk - foslevodopa; foscarbidopa hydrate - colorless to yellow or brown limpid injection. it may have a reddish or purplish tinge or a slight opalescent light.

Produodopa 240 mg/ml - 12 mg/ml inf. sol. s.c. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

produodopa 240 mg/ml - 12 mg/ml inf. sol. s.c. vial

abbvie sa-nv - foslevodopa 240 mg - eq. levodopa 170 mg; foscarbidopa 12 mg - eq. carbidopa 9 mg - solution for infusion - foslevodopa and decarboxylase inhibitor

ALLERGY COMPOSITION- chondrus crispus, glycyrrhiza glabra, zingiber officinale, ambrosia artemisiaefolia, histaminum hydrochlori United States - English - NLM (National Library of Medicine)

allergy composition- chondrus crispus, glycyrrhiza glabra, zingiber officinale, ambrosia artemisiaefolia, histaminum hydrochlori

synergy formulas, inc. - chondrus crispus (unii: oqs23hua1x) (chondrus crispus - unii:oqs23hua1x), glycyrrhiza glabra (unii: 2788z9758h) (glycyrrhiza glabra - unii:2788z9758h), ginger (unii: c5529g5jpq) (ginger - unii:c5529g5jpq), ambrosia artemisiifolia (unii: 9w34l2cq9a) (ambrosia artemisiifolia - unii:9w34l2cq9a), histamine dihydrochloride (unii: 3poa0q644u) (histamine - unii:820484n8i3), etilevodopa (unii: 895x917gye) (etilevodopa - unii:895x917gye), schoenocaulon officinale seed (unii: 6naf1689io) (schoenocaulon officin - for temporary relief of hay fever symptoms, sinus congestion, bronchial irritation, itching of eyelids.  for temporary relief of stuffy nose with headache, cough and hoarseness.  for temporary relief of hay fever symptoms, sinus congestion, bronchial irritation, itching of eyelids. for temporary relief of stuffy nose with headache, cough and hoarseness.

LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN Ireland - English - HPRA (Health Products Regulatory Authority)

levodopa/carbidopa/entacapone mylan

generics (uk) limited - levodopa ; carbidopa ; entacapone - film coated tablet - 50/12.5/200 milligram - levodopa, decarboxylase inhibitor and comt inhibitor

LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN Ireland - English - HPRA (Health Products Regulatory Authority)

levodopa/carbidopa/entacapone mylan

generics (uk) limited - levodopa ; carbidopa ; entacapone - film coated tablet - 75/18.75/200 milligram - levodopa, decarboxylase inhibitor and comt inhibitor